WIPO trademark

CYTOSPIRE

MixedWIPOClass 5Class 42

"CYTOSPIRE" is a trademark owned by Cytospire Therapeutics Limited, filed at the WIPO on June 26, 2026. It is on file and covers classes 5 and 42.

View Cytospire Therapeutics Limited portfolioGet this data via the API
CYTOSPIRE
Trademark as filed with the WIPO
Status
Mixed
Filed
June 26, 2026
Registered
Not yet
Expires
June 26, 2036
Application no.
Not recorded
Registration no.
1930815
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
2 classes
Ownership

Who owns CYTOSPIRE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Cytospire Therapeutics Limited

United Kingdom

1 trademarks in the portfolioView company

Representative

CMS Cameron McKenna Nabarro Olswang LLP

CMS Cameron McKenna Nabarro Olswang LLP

Goods and services

What the mark covers

The products and services CYTOSPIRE is filed for, grouped by Nice class.

  • Pharmaceutical preparations; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the prevention and treatment of cancer and tumours; pharmaceutical preparations for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; biological preparations for medical purposes; biological preparations for the prevention and treatment of cancer and tumours; biological preparations for use in the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; biological preparations for use in the prevention and treatment of cancer and tumours; biopharmaceuticals for the treatment of cancer; antibodies; diagnostic reagents for medical use.

  • Scientific and technological services; scientific research; pharmaceutical research and development services; medical research services; drug development services; laboratory analysis; laboratory research; laboratory testing; testing of pharmaceuticals; pharmaceutical research and development services in the field of oncology and immunotherapy; pharmaceutical research and development of pharmaceuticals and drugs for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; medical research services in the field of oncology and immunotherapy; medical research services for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; drug development services in the field of oncology and immunotherapy; drug development services for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; laboratory research and testing of pharmaceuticals in the field of oncology and immunotherapy; laboratory research and testing of pharmaceuticals for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; research and development services in the field of antibodies; research and development in the field of biotechnology; development of antibodies; development of antibodies for use in the field of oncology and immunotherapy; information, consultancy and advice in relation to the aforesaid services.

FAQ

About CYTOSPIRE

Who owns the trademark "CYTOSPIRE"?

The WIPO trademark "CYTOSPIRE" is owned by Cytospire Therapeutics Limited.

What is the status of "CYTOSPIRE"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CYTOSPIRE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_80700c3c-a685-478d-854c-ac1394e891fc
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_80700c3c-a685-478d-854c-ac1394e891fc",
  "object": "trademark",
  "mark_text": "CYTOSPIRE",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2026-06-26",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Cytospire Therapeutics Limited",
      "entity_id": "ent_019fd8ee-9c9b-719c-9d0f-4e857ea0c019"
    }
  ]
}